Atlas Trials

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer

Clinical trial NCT00276861 · TERMINATED

Trial details

NCT number
NCT00276861
Sponsor
University of Miami
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2005-09-01
Primary completion
2006-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.